Trump pharmaceutical tariff threat lessens after Pfizer deal
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with…
Using options to trade this pharma name that has multiple tailwinds in its favor
Gilead’s (GILD) recent breakout to new 52-week highs is constructive and reflects improving investor sentiment around its leadership…
Trump asks drugmakers to cut U.S. prices within 60 days
U.S. President Donald Trump, U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., Dr. Mehmet Oz,…